Enzyme-based medical products

Enzymatica

Enzymatica is based in Lund, Sweden, and sells medical devices against infectious diseases. The company's first product is ColdZyme® Munspray, which is marketed for cold virus prophylaxis and anti-cold virus therapeutic.

Financials

ENZYMATICA

SEKm 2017 2018 2019
Sales 59 53 64
Sales growth (%) 62,9 -10,1 20
EBITDA -22 -47 -40
EBITDA margin (%) -36,9 -87,8 -62,3
EBIT adj -30 -56 -45
EBIT adj margin (%) -50,8 -104,6 -70,6
Pretax profit -31 -81 -70
EPS rep -0,35 -0,88 -0,77
EPS growth (%) 50,2 -155,7 12,9
EPS adj -0,35 -0,88 -0,77
DPS 0 0 0
EV/EBITDA (x) -20,7 -7,1 -9,5
EV/EBIT adj (x) -15 -6 -8,4
P/E (x) -14,6 -3,3 -3,8
P/E adj (x) -14,6 -3,3 -3,8
EV/sales (x) 7,6 6,3 5,9
FCF yield (%) -5,2 -30,4 -16,9
Dividend yield (%) 0 0 0
Net IB debt/EBITDA 0,2 -1,5 -2,9